ClinConnect ClinConnect Logo
Search / Trial NCT05758012

Carbetocin Compared To Oxytocin During Cesarean Delivery

Launched by ASSIUT UNIVERSITY · Mar 4, 2023

Trial Information

Current as of May 05, 2025

Unknown status

Keywords

ClinConnect Summary

Although the difference between carbetocin and oxytocin in terms of hemodynamic changes, postpartum blood loss and incidence of side effects is not statistically significant. serious cardiovascular adverse events, including ST segment depression, hypotension and tachycardia have been reported after IV oxytocin. Oxytocin dose reduction and/or increased infusion duration may reduce risk of some cardiac-related adverse effects and increase patient safety. As both oxytocin and carbetocin are used daily in obstetric units all over the world, the investigators find it compelling to investigate wh...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Normal singleton pregnancy at gestational age of 36 weeks or more.
  • Women with common comorbid diagnoses (diabetes, hypothyroidism, hypertension)
  • pregnancy after in vitro fertilization
  • Exclusion Criteria:
  • placenta praevia or invasive placenta.
  • pre-eclampsia.
  • Bleeding disorder, such as von Willebrand disease type I.
  • Current treatment with low-molecular-weight heparin or other anticoagulation medication (not including aspirin).
  • Any known intolerance to either of the study drugs.
  • Prolonged QT-time.
  • Other serious cardiac disease.
  • Liver or kidney failure.

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

Kuwait, , Kuwait

Patients applied

0 patients applied

Trial Officials

Fatemah Qasem

Principal Investigator

Ministry of Health, Kuwait

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials